Holen Sie sich die Stockscreener-App
32.15
0.16%
0.05
Handel nachbörslich:
32.31
0.16
+0.50%
Schlusskurs vom Vortag:
$32.10
Offen:
$31.88
24-Stunden-Volumen:
1.36M
Relative Volume:
0.96
Marktkapitalisierung:
$4.17B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-507.65M
KGV:
-6.9891
EPS:
-4.6
Netto-Cashflow:
$-616.24M
1W Leistung:
+4.48%
1M Leistung:
-4.66%
6M Leistung:
-54.23%
1J Leistung:
-70.55%
1-Tages-Spanne:
$30.89
$32.22
1-Wochen-Bereich:
$30.32
$32.32
52-Wochen-Spanne:
$27.66
$121.06
Vaxcyte Inc Stock (PCVX) Company Profile
Firmenname
Vaxcyte Inc
Sektor
Branche
Telefon
650-837-0111
Adresse
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
Vergleichen Sie PCVX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCVX
Vaxcyte Inc
|
32.15 | 4.10B | 0 | -507.65M | -616.24M | -4.60 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vaxcyte Inc Stock (PCVX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Eingeleitet | Goldman | Buy |
| 2023-12-07 | Eingeleitet | Mizuho | Buy |
| 2023-04-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-03 | Bestätigt | Needham | Buy |
| 2022-12-15 | Eingeleitet | Guggenheim | Buy |
| 2022-11-17 | Eingeleitet | BTIG Research | Buy |
| 2021-12-29 | Fortgesetzt | Jefferies | Buy |
| 2021-06-24 | Fortgesetzt | Jefferies | Buy |
| 2020-07-07 | Eingeleitet | BofA Securities | Buy |
| 2020-07-07 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-07-07 | Eingeleitet | Needham | Buy |
Alle ansehen
Vaxcyte Inc Aktie (PCVX) Neueste Nachrichten
How to forecast Vaxcyte Inc. trends using time seriesPortfolio Return Summary & Daily Entry Point Trade Alerts - Newser
Vaxcyte Says VAX-31 Pneumococcal Disease Study Advances to Final Stage - MarketScreener
Vaxcyte advances VAX-31 pneumococcal vaccine to final stage of infant study - Investing.com
Vaxcyte Advances VAX-31 Infant Phase 2 Dose-Finding Study with First Participants Receiving VAX-31 Optimized Dose - GlobeNewswire
92% Disease Coverage: Vaxcyte's VAX-31 Could Become Broadest Pneumococcal Vaccine for Infants - Stock Titan
What recovery options are there for Vaxcyte Inc.2025 Top Gainers & High Conviction Investment Ideas - Newser
How to build a custom watchlist for Vaxcyte Inc.July 2025 Update & Community Supported Trade Ideas - Newser
Will Vaxcyte Inc. stock recover after earningsPortfolio Performance Summary & AI Enhanced Trading Alerts - khodrobank.com
Evaluating Vaxcyte Inc. with trendline analysisWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
How institutional ownership impacts Vaxcyte Inc. stockMarket Sentiment Report & Verified Swing Trading Watchlist - Newser
What is the target price for Vaxcyte Inc. stock2025 Trading Volume Trends & Trade Opportunity Analysis Reports - khodrobank.com
Short interest data insights for Vaxcyte Inc.Volume Spike & Reliable Entry Point Alerts - Newser
How to interpret RSI for Vaxcyte Inc. stockWeekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
Multi factor analysis applied to Vaxcyte Inc.Trade Volume Summary & Risk Controlled Stock Pick Alerts - Newser
Vaxcyte Inc. stock outlook for YEARPortfolio Performance Summary & Consistent Growth Equity Picks - Newser
What indicators show strength in Vaxcyte Inc.2025 Market Trends & AI Forecasted Entry and Exit Points - Newser
How to manage a losing position in Vaxcyte Inc.July 2025 Price Swings & AI Based Buy and Sell Signals - Newser
Is Vaxcyte Inc. forming a bottoming baseWeekly Trend Recap & AI Powered Trade Plan Recommendations - Newser
Analyzing Vaxcyte Inc. with risk reward ratio chartsPortfolio Update Report & Weekly High Conviction Trade Ideas - Newser
Is Vaxcyte Inc. stock good for income investorsWeekly Earnings Recap & Weekly Momentum Picks - khodrobank.com
Market Wrap: Can Vaxcyte Inc. expand its profit marginsPortfolio Risk Report & Reliable Trade Execution Plans - khodrobank.com
Is Vaxcyte Inc. in a bullish channelQuarterly Portfolio Review & Safe Capital Growth Tips - khodrobank.com
Is Vaxcyte Inc. stock reversal real or fakeTrade Analysis Summary & Weekly Market Pulse Updates - Newser
Vaxcyte Inc. stock trend forecast2025 Trading Recap & Fast Exit and Entry Strategy Plans - Newser
Insider Sell: What is the PEG ratio of Vaxcyte Inc.July 2025 Spike Watch & Consistent Return Investment Signals - khodrobank.com
What is the long term forecast for Vaxcyte Inc. stock2025 Sector Review & Growth Focused Investment Plans - khodrobank.com
Risk vs reward if holding onto Vaxcyte Inc.Portfolio Growth Summary & Long-Term Investment Growth Plans - Newser
InvestingPro’s Fair Value model predicted Vaxcyte’s 46% decline By Investing.com - Investing.com
Visualizing Vaxcyte Inc. stock with heatmapsShort Setup & Long Hold Capital Preservation Plans - Newser
Full technical analysis of Vaxcyte Inc. stockTrade Risk Summary & Reliable Entry Point Trade Alerts - Newser
Market Outlook: How does Vaxcyte Inc. compare to its peersQuarterly Portfolio Report & Safe Capital Growth Trade Ideas - khodrobank.com
Momentum Shift: What are Vaxcyte Inc.’s recent SEC filings showing2025 Big Picture & Low Drawdown Trading Strategies - khodrobank.com
Is Vaxcyte Inc. vulnerable to short sellersTrade Volume Summary & Low Drawdown Investment Strategies - khodrobank.com
Advanced analytics toolkit walkthrough for Vaxcyte Inc.2025 Bull vs Bear & Comprehensive Market Scan Reports - Newser
Can Vaxcyte Inc. Regain Lost Ground This Quarter getLinesFromResByArray error: size == 0 - kangso.co.kr
Published on: 2025-08-31 17:30:01 - Newser
Reversal indicators forming on Vaxcyte Inc. stockJuly 2025 Decliners & Reliable Momentum Entry Alerts - Newser
Is Vaxcyte Inc. forming a reversal patternJuly 2025 Intraday Action & AI Forecasted Entry and Exit Points - Newser
Using data models to predict Vaxcyte Inc. stock movementJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - Newser
How to track smart money flows in Vaxcyte Inc.Exit Point & Consistent Return Investment Signals - Newser
Finanzdaten der Vaxcyte Inc-Aktie (PCVX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vaxcyte Inc-Aktie (PCVX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| GUGGENHIME ANDREW | PRESIDENT AND CFO |
Apr 07 '25 |
Option Exercise |
20.93 |
4,777 |
99,983 |
131,950 |
| PICKERING GRANT | CHIEF EXECUTIVE OFFICER |
Apr 04 '25 |
Option Exercise |
8.96 |
20,533 |
183,888 |
518,775 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Option Exercise |
21.41 |
5,000 |
107,050 |
46,620 |
| Eydelman Mikhail | SVP, GEN COUNSEL & CORP SEC |
Mar 05 '25 |
Sale |
70.74 |
5,000 |
353,699 |
41,620 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):